G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 113 filers reported holding G1 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $32,522 | -16.6% | 12,135 | +137.1% | 0.00% | – |
| Q1 2022 | $39,000 | -25.0% | 5,118 | 0.0% | 0.00% | – |
| Q4 2021 | $52,000 | -24.6% | 5,118 | 0.0% | 0.00% | – |
| Q3 2021 | $69,000 | -38.4% | 5,118 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $112,000 | -8.9% | 5,118 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $123,000 | +33.7% | 5,118 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $92,000 | +178.8% | 5,118 | +80.2% | 0.00% | – |
| Q3 2020 | $33,000 | -52.2% | 2,840 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $69,000 | +475.0% | 2,840 | +158.4% | 0.00% | – |
| Q1 2020 | $12,000 | -58.6% | 1,099 | 0.0% | 0.00% | – |
| Q4 2019 | $29,000 | +16.0% | 1,099 | 0.0% | 0.00% | – |
| Q3 2019 | $25,000 | -26.5% | 1,099 | 0.0% | 0.00% | – |
| Q2 2019 | $34,000 | +88.9% | 1,099 | 0.0% | 0.00% | – |
| Q1 2019 | $18,000 | -14.3% | 1,099 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -12.5% | 1,099 | +134.8% | 0.00% | – |
| Q3 2018 | $24,000 | – | 468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |